PHARMAFILM

Serial Number 77237564
602

Registration Progress

Application Filed
Jul 24, 2007
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: PHARMAFILM
Previous Owner: Akela Pharma Inc.
Classes: 005

Trademark Image

PHARMAFILM

Basic Information

Serial Number
77237564
Filing Date
July 24, 2007
Abandonment Date
April 10, 2008
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
May 6, 2008
Classes
005

Rights Holder

Akela Pharma Inc.

03
Address
3333 Cote-Vertu Blvd., Suite 710
Saint-Laurent, Quebec H4R2N1
CA

Ownership History

Akela Pharma Inc.

Original Applicant
03
Saint-Laurent, Quebec CA

Legal Representation

Attorney
ERIC B MEYERTONS

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

9 events
Date Code Type Description Documents
May 7, 2008 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
May 6, 2008 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Dec 18, 2007 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 18, 2007 ALIE A ASSIGNED TO LIE Loading...
Nov 6, 2007 MAIL I PAPER RECEIVED Loading...
Oct 9, 2007 CNRT F NON-FINAL ACTION MAILED Loading...
Oct 9, 2007 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 2, 2007 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 27, 2007 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system; Pharmaceutical preparations and substances for use in pain control and pain management, arthritis, anesthesia, asthma, oncology, urology, gynecology; Pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections; Pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases and arthritis; Pharmaceutical preparations and substances for the treatment and prevention of diabetes; Chemicals relating to drug performance and/or drug delivery performance for research use and manufacturing in the biotechnical, biomedical and pharmaceutical industries; Inhalers and applicators for the prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system; Inhalers and applicators for use in pain control, asthma treatment, arthritis, anesthesia, oncology, infection, inflammation, urology, gynecology, dental care, surgery and radiology; Inhalers and applicators for the treatment and prevention of diabetes; Apparatus and instruments for use in pain control and pain management, arthritis, asthma, anesthesia, oncology, infection, inflammation, urology, gynecology, dental care, surgery respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system and radiology; apparatus and instruments for the treatment and prevention of diabetes; prepared and processed proteins and myco-proteins for human consumption; Medical devices, namely, medical apparatus, namely, a unit for aerosol drug delivery to the deep lung of drugs as fine, dry particles; Chemicals for use in the manufacture of pharmaceuticals, namely, peptides, polypeptides, molecules, enzymes substrates, natural extracts, active principles, reactives, solvents, metals, metalloids; chemicals for use in the manufacture of cosmetics; Pharmaceutical, veterinary and sanitary preparations and dietetic substances adapted for medical use, namely, psychotropic, cardiovascular agents, vasotherapeutics in the form of ampoule, tablets or liquid, anti-infective, antibiotics, chemotherapeutics, antiviral agents, hormones, metabolic agents in the form of caplets or liquid or particulate inhaleable formulation, namely, peptides, polypeptides, opiods, opiod derivatives, pain agents, amino acids, peptides, creatine, dextrose, vitamin C, antidiabetic drugs, agents for digestive disorders, namely, antiacids, anti-diarrhea and antiemetics in the form of liquid or caplets, antiallergic drugs, analgesics, spasmolytic drugs, narcotics, anesthetics, antiphlogistic, antirheumatic and anti asthmatic agents; Dermatological preparations, namely, creams for the treatment of pain, acne, eczema, dry skin, psoriasis and other immune system controlling agents, namely, vaccines, drugs to treat osteoporosis, tumor therapeutics; Biological products, namely, for pharmaceutical, clinical or medical laboratory use, namely, biological reagents for diagnostic and scientific purposes, antiemetics, pain treatment drugs, vaccines, infusions of said drugs; Plasters, namely, material plasters, adhesive plasters, mucosa plasters, drug bearing plasters and films, materials for dressings; material for stopping teeth: Surgical, medical, dental and veterinary apparatus and instruments, namely, aerosol dispensers for medical purposes, injectors for medical purposes, pumps for medical purposes; tissues and materials impregnated with pharmaceutical substances, namely, opiod bearing films; Pharmaceutical and veterinary products in the form of caplets, liquid to be administrated by injection, liquid to be orally administrated for the prevention and treatment of obesity, smoking cessation, nephropathy, pulmonary embolism, atherothrombosis, asthma, hypertension, thrombosis, arrhythmia, angina, hypertension, heart failure, insomnia, epilepsy, schizophrenia, fever and pain; Pharmaceutical preparations for the treatment of the central nervous system, namely, neurotic and psychosomatic disorder, namely, anxiety, depression, hysteria, stress, fears; prostatic hyperplasia, granuloma inguinale, bilharziasis, and other protozoal infections, namely, babesios, coccidiosis, cryptosporidiosis, malaria, toxoplasmosis, trichomoniasis, trypanosomiasis
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005